FDA Investigator Sam H Haidar, PhD
Sam H Haidar, PhD has conducted inspections on 12 sites in 6 countries as of 20 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Israel,
Jordan,
South Africa,
Switzerland
FDA Investigators that have inspected at least one site in common with Sam H Haidar, PhD:
Alanna L Mussawwir Bias,
Albert F Peacock, PhD,
Allen F Hall,
Andrea A Branche,
Andrea D Swingle,
Angel S Johnson,
Anita Narula, PhD,
Anthony E Keller, RPh,
Arindam Dasgupta, PhD,
Barbara J Holladay,
Barbara T Carmichael,
Brandon L Mariner,
Brandy D Brown,
Brooke K Higgins,
Camille D Brown,
Candice C Mandera,
Candice J Cortes,
Carol A Gripp,
Carol Rivera Lopez, PhD,
CDR Kimberly Y Martin,
Chaoying C Ma,
Charles M Kerns, BLT DO,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
Daniel L Aisen,
David L Chon,
Dawn C Olenjack,
Dennis Cantellops Paite,
Dianne H Milazzo,
Dipesh K Shah,
Dr. Abhijit Raha, PhD,
Dr. Carmelo Rosa,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Edward D Mcdonald,
Edward J Janik,
Elise A Murphy,
Eric E Joneson,
Erin L Mcfiren,
Gajendiran Mahadevan, PhD,
Gavin T Cua,
Gene R Gunn,
Gifford Whitehurst, Jr,
Hugh M Mcclure, II,
Huixia Zhang,
Jacob G Lutz,
Jacqueline A O'shaughnessy, PhD,
Janete F Guardia,
Jennifer C Adams,
Jodi M Gatica,
John A Kadavil, PhD,
John Dan,
Jose A Lopez,
Jose M Cayuela,
Justin A Boyd,
Kara A Scheibner, PhD,
Katherine Szestypalow,
Kip J Hanks,
Larry K Austin,
Lata C Mathew, PhD,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Li Hongpaul Yeh, PhD,
Libia M Lugo,
Lisa B Orr,
Lori J Silverstein,
Maan S Abduldayem,
Makini Cobourne Duval, PhD,
Margaret M Annes,
Martin K Yau, PhD,
Matthew B Casale,
Michael A Taylor,
Michael F Skelly, PhD,
Michael L Chasey,
Michele L Glendenning,
Mohsen Rajabi Abhari, FDA,
Nancy A Bellamy,
Nathaniel R Esaw,
Nicola M Fenty Stewart,
Patrick D Stone, MS,
Paul L Bellamy,
Peter R Lenahan,
Ramon A Hernandez,
Randy L Self,
Raymond T Oji,
Robert Barron,
Robert J Doyle,
Ruben C Ayala, PharmD,
Samantha J Pinizzotto, D V M,
Samuel H Chan, PharmD,
Sandra A Boyd,
Sandra A Hughes,
Scott B Laufenberg,
Sean Y Kassim, PhD,
Seongeun Cho (Julia), PhD,
Sherry L Secrist, BLT DO,
Shirley H Isbill,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stephanie Mangigian, MS/OSH, RN,
Tamal K Chakraborti, PhD,
Tawny L Colling,
Theressa B Smith,
William H Linkroum,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD,
Yumi J Hiramine,
Zachary A Bogorad
Sam H Haidar, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2019 | EIR | PPD Development, L.P. - EIR, 2019-11-18 |
April, 2014 | EIR | Celerion Switzerland AG - EIR, 2014-04-11 |
December, 2010 | FDA 483 | Cetero Research - Form 483, 2010-12-10 |
October, 2014 | FDA 483 | Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - Form 483, 2014-10-09 |
September, 2013 | EIR | Glenmark Pharmaceuticals Limited - EIR, 2013-09-25 |
April, 2014 | EIR | Parexel Bionanalytical Services Division - EIR, 2014-04-04 |
June, 2014 | EIR | LABCORP DRUG DEVELOPMENT INC. - EIR, 2014-06-06 |
October, 2014 | EIR | Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - EIR, 2014-10-09 |
October, 2014 | FDA 483 Response | Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - Form 483R, 2014-12-19 |
May, 2016 | EIR | COVANCE BIOANALYTICAL SERVICES, LLC - EIR, 2023-11-06 |
September, 2013 | FDA 483 | Glenmark Pharmaceuticals Limited - Form 483, 2013-09-25 |
October, 2014 | FDA 483 | Quest Life Sciences Pvt., Ltd. - Form 483, 2014-10-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more